Provided by:
Abramson Cancer Center of the University of
Pennsylvania Morbidity and Mortality Conference
2015
Morbidity and Mortality Conference
Wednesday, October 21, 2015
8:00-9:00 a.m.
Smilow Center for Translational Research, Rubenstein Auditorium
Allyson Pishko, Fellow
Hematology Oncology, HUP
DIFFICULT DECISIONS IN MULTIPLE MYELOMA
Nicholas McAndrew, Fellow
Hematology Oncology, HUP
MORBIDITY AND MORTALITY: POST-OBSTRUCTIVE PNEUMONIA
Target Audience
This program has been designed for departmental/institutional faculty, fellows, and residents in the medical specialties
of hematology/oncology and radiation/oncology
Educational Objectives
After completing this activity, participants should be able to:
 Describe and define the pathophysiology and etiology of oncologic diseases
 Explain and employ new diagnostic methods for different oncologic diseases
 Formulate and prescribe a management plan for different oncologic diseases
 Assess and grade prognostic information for different oncologic diseases
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA
PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in
the activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Joy Junious
215-662-3917
juniousj@uphs.upenn.edu
Check your CME online at www.penncmeonline.com
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to
control the content of an educational activity to disclose to the learners all relevant financial relationships that they have
with any commercial interest that provides products or services that may be relevant to the content of this continuing
medical education activity. For this purpose we consider relationships of the person involved in the CME activity to
include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from
involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in
improving medical practice, are based on valid content, and are independent of control from commercial interests and
free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure
information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest
relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically
rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic,
Director of CME and the peer reviewer Zalman Agus, MD, have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests
related to the content of this educational activity:
PLANNING COMMITTEE NAME
JOSEPH CARVER, MD
PRESENTER NAME
NINA BERI, MD
DAVID GUTTMAN
CHRISTINE MCMAHON, MD
ALLYSON PISHKO, MD
ADAM WAXMAN
CHI DANG, MD, PHD
ELI GLATSTEIN, MD
PAMELA BOIMEL
NATHAN HANDLEY, MD
NICHOLAS MCANDREW, MD
CAITLIN SCHONEWAZ
AARON COHEN, MD
THOMAS KARASIC, MD
SARAH NAGLE, MD, PHD
JENNIFER VOGEL
The following individuals have reported the listed relevant financial relationships with commercial interests related to
the content of this educational activity.
PLANNING COMMITTEE NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
ALISON LOREN, MD
MERCK
SITE PI
SELINA LUGER, MD
PFIZER
DSMB CONSULTANT
SIGMA TAU & KARYOPHARM
ADVISORY BOARD
CYCLACEL & AMGEN
CLINICAL TRIAL
DAVID VAUGHN, MD
ASTELLAS
DSMB CONSULTANT
PRESENTER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty,
intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding
diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position,
independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels,
board membership, and other activities from which remuneration is received or expected
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
PRODUCT
INVESTIGATIONAL AND/OR OFF-LABEL USE